5 - All research
Permanent URI for this communityhttps://hdl.handle.net/2164/705
Browse
14 results
Search Results
Item Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? : A case-study focusing on disease-modifying therapies for treatment of multiple sclerosis(2022-12-13) Armoiry, Xavier; Wang-Steverding, Xia; Connock, Martin; Grove, Amy; Clarke, Aileen; Arun, Tarunya; Counsell, Carl; Auguste, Peter; University of Aberdeen.Institute of Applied Health Sciences; University of Aberdeen.Chronic Disease Research Group; University of Aberdeen.Other Applied Health SciencesItem Multiple sclerosis, emotion perception and social functioning(2021-09) Radlak, Bogna; Cooper, Clare; Summers, Fiona; Phillips, Louise H; University of Aberdeen.Aberdeen Health Psychology Group; University of Aberdeen.PsychologyItem Characterizing chronic pain phenotypes in multiple sclerosis : a nationwide survey study(2021-05) Kratz, Anna L.; Whibley, Daniel; Alschuler, Kevin N; Ehde, Dawn; Williams, David; Clauw, Daniel J.; Braley, Tiffany J.; University of Aberdeen.Other Applied Health SciencesItem Calling Out MS Fatigue : Feasibility and Preliminary Effects of a Pilot Randomized Telephone-Delivered Exercise Intervention for Multiple Sclerosis Fatigue(2020-01-01) Kratz, Anna L.; Atalla, Mareena; Whibley, Daniel; Myles, Abigail; Thurston, Taylor; Fritz, Nora E.; University of Aberdeen.Other Applied Health SciencesItem IL-12p35 Inhibits Neuroinflammation and Ameliorates Autoimmune Encephalomyelitis(2017-10-05) Choi, Jin Kyeong; Dambuza, Ivy M; He, Chang; Yu, Cheng-Rong; Uche, Anita N; Mattapallil, Mary J; Caspi, Rachel R; Egwuagu, Charles E; University of Aberdeen.Applied MedicineItem Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis : systematic review and network meta-analysis of trials including recommended dosages(2018-10-03) Melendez-Torres, G. J.; Armoiry, Xavier; Court, Rachel; Patterson, Jacoby; Kan, Alan; Auguste, Peter; Madan, Jason; Counsell, Carl; Ciccarelli, Olga; Clarke, Aileen; University of Aberdeen.Grampian Data Safe Haven (DaSH); University of Aberdeen.Chronic Disease Research Group; University of Aberdeen.Other Applied Health Sciences; University of Aberdeen.Institute of Applied Health SciencesItem Season of infectious mononucleosis as a risk factor for multiple sclerosis : a UK primary care case-control study(2017-10) Downham, Christina; Visser, Elizabeth; Vickers, Mark; Counsell, Carl; University of Aberdeen.Other Applied Health Sciences; University of Aberdeen.Applied Medicine; University of Aberdeen.Chronic Disease Research Group; University of Aberdeen.Grampian Data Safe Haven (DaSH); University of Aberdeen.Institute of Applied Health SciencesItem Identity Concealment and Chronic Illness : A Strategic Choice(2017-06) Cook, Jonathan E.; Salter, Amber; Stadler, Gertraud; University of Aberdeen.Other Applied Health Sciences; University of Aberdeen.Institute of Applied Health SciencesItem Blood Mononuclear Cell Mitochondrial Respiratory Chain Complex IV Activity Is Decreased in Multiple Sclerosis Patients : Effects of β-Interferon Treatment(2018-02-20) Hargreaves, Iain; Mody, Nimesh; Land, John; Heales, Simon; University of Aberdeen.Medical Sciences; University of Aberdeen.Medical Sciences - Cardiovascular GroupItem Anger, Quality of Life and Mood in Multiple Sclerosis(2015) Laing, Christianne M; Phillips, Louise H; Cooper, Clare L; Hosie, Judith A; Summers, Fiona; University of Aberdeen.Psychology; University of Aberdeen.Other Applied Health Sciences; University of Aberdeen.Institute of Applied Health Sciences